Physician

Amita D Bishnoi-Singh, M.D.

According to 2025 Medicare claims, Amita Bishnoi-Singh, M.D. (NPI: 1427151067) practices rheumatology in the Warren-Troy-Farmington Hills, MI market, with the plurality of this provider's patient population coming from Macomb, MI. This provider's primary affiliated billing organization is HENRY FORD HEALTH SYSTEM (NPI: 1891702833; TIN: 38-1357020) and primary practice location at 48313-1229. Bishnoi-Singh is affiliated with the Mosaic ACO (ACO ID: A5033), participating under the MSSP model.

Bishnoi-Singh's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 230 traditional Medicare patients, billed 679 HCPCS/CPT codes, and received $34,386 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 2,273 prescription claims across 438 beneficiaries totaling $3,753,783 in drug costs, led by Enbrel Sureclick (Etanercept). Open Payments data shows 1 records totaling $21. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,111,119 to $3,753,783. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	248	407	$29,169
2016	257	379	$25,845
2017	240	350	$22,575
2018	245	337	$24,623
2019	279	392	$27,032
2020	239	412	$25,633
2021	235	421	$31,013
2022	251	372	$29,866
2023	232	341	$26,593
2024	230	679	$34,386

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	312	2,227	$1,111,119
2016	301	2,060	$1,472,835
2017	299	2,110	$1,705,082
2018	306	1,955	$1,930,468
2019	411	2,000	$2,286,217
2020	403	2,040	$2,499,957
2021	420	2,103	$3,263,443
2022	464	2,198	$3,571,485
2023	458	2,142	$3,449,589
2024	438	2,273	$3,753,783

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	40	40	$129
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	76	92	$101
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	139	194	$66
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	188	274	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Enbrel Sureclick	Etanercept	132	3,864	$915,436
Humira(Cf) Pen	Adalimumab	93	2,632	$901,831
Humira Pen	Adalimumab	70	2,016	$530,890
Orencia Clickject	Abatacept	46	1,372	$265,421
Enbrel	Etanercept	20	560	$139,339

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$21	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Amita D. Bishnoi-Singh, M.D.?

Tedicare shows public-source Medicare data for Amita D. Bishnoi-Singh, M.D. (NPI 1427151067), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amita D. Bishnoi-Singh, M.D. have ACO affiliation data?

Amita D. Bishnoi-Singh, M.D. is shown with ACO affiliation data for Mosaic ACO (MSSP, ACO ID A5033).

What billing organization is linked to Amita D. Bishnoi-Singh, M.D.?

Amita D. Bishnoi-Singh, M.D. is linked to HENRY FORD HEALTH SYSTEM (billing NPI 1891702833) in the available physician profile data.

Does Amita D. Bishnoi-Singh, M.D. have Open Payments data?

Amita D. Bishnoi-Singh, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.